Obesity treatment

EndoZip™ Begins Pivotal Trial to Advance Automated ESG in U.S.

CAESAREA, Israel, Dec. 10, 2025 — Nitinotes Ltd., an early commercial-stage medical technology company developing fully automated endoluminal suturing...

By cGxPwire Editor
December 11, 2025

Bio-Pharma

Mazdutide 9mg Enters NMPA Review, Advancing Obesity Treatment

BEIJING, China, Nov. 25, 2025 — Innovent Biologics and Eli Lilly announced that the supplementary application for Mazdutide 9mg...

By cGxPwire Editor
November 25, 2025

Bio-Pharma M&A

Wave Life Sciences’ RNA Breakthrough Targets Obesity and Liver Disorders

BOSTON, October 29, 2025 — Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology leader in RNA medicines, has...

By cGxPwire Editor
October 30, 2025

Pharma

Lilly Invests $6.5 B to Build API Plant in Houston

Houston, Texas – September 23, 2025 — Eli Lilly and Company (NYSE: LLY) will invest $6.5 billion to build...

By cGxPwire Editor
September 23, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

EndoZip™ Begins Pivotal Trial to Advance Automated ESG in U.S.

Mazdutide 9mg Enters NMPA Review, Advancing Obesity Treatment

Wave Life Sciences’ RNA Breakthrough Targets Obesity and Liver Disorders

Lilly Invests $6.5 B to Build API Plant in Houston